187 related articles for article (PubMed ID: 19903851)
1. Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.
Datta D; Contreras AG; Basu A; Dormond O; Flynn E; Briscoe DM; Pal S
Cancer Res; 2009 Dec; 69(23):8902-9. PubMed ID: 19903851
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.
Basu A; Banerjee P; Contreras AG; Flynn E; Pal S
PLoS One; 2011; 6(8):e23919. PubMed ID: 21886838
[TBL] [Abstract][Full Text] [Related]
3. The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.
Banerjee P; Basu A; Arbiser JL; Pal S
Cancer Lett; 2013 Sep; 338(2):292-9. PubMed ID: 23752066
[TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
Balan M; Chakraborty S; Flynn E; Zurakowski D; Pal S
Sci Rep; 2017 Jul; 7(1):5900. PubMed ID: 28724911
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.
Datta D; Contreras AG; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
J Am Soc Nephrol; 2008 Dec; 19(12):2437-46. PubMed ID: 18832436
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506.
Akool el-S; Doller A; Babelova A; Tsalastra W; Moreth K; Schaefer L; Pfeilschifter J; Eberhardt W
J Immunol; 2008 Aug; 181(4):2831-45. PubMed ID: 18684975
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
Majid S; Saini S; Dar AA; Hirata H; Shahryari V; Tanaka Y; Yamamura S; Ueno K; Zaman MS; Singh K; Chang I; Deng G; Dahiya R
Cancer Res; 2011 Apr; 71(7):2611-21. PubMed ID: 21330408
[TBL] [Abstract][Full Text] [Related]
8. Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin.
Pan F; Sun L; Kardian DB; Whartenby KA; Pardoll DM; Liu JO
Nature; 2007 Jan; 445(7126):433-6. PubMed ID: 17230191
[TBL] [Abstract][Full Text] [Related]
9. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.
Sun H; King AJ; Diaz HB; Marshall MS
Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905
[TBL] [Abstract][Full Text] [Related]
11. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.
Rodrigues-Diez R; González-Guerrero C; Ocaña-Salceda C; Rodrigues-Diez RR; Egido J; Ortiz A; Ruiz-Ortega M; Ramos AM
Sci Rep; 2016 Jun; 6():27915. PubMed ID: 27295076
[TBL] [Abstract][Full Text] [Related]
13. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
Sugimoto T; Stewart S; Han M; Guan KL
EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
[TBL] [Abstract][Full Text] [Related]
15. Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.
Balan M; Mier y Teran E; Waaga-Gasser AM; Gasser M; Choueiri TK; Freeman G; Pal S
J Biol Chem; 2015 Mar; 290(13):8110-20. PubMed ID: 25645920
[TBL] [Abstract][Full Text] [Related]
16. Evidence for aldosterone-dependent growth of renal cell carcinoma.
King S; Bray S; Galbraith S; Christie L; Fleming S
Int J Exp Pathol; 2014 Aug; 95(4):244-50. PubMed ID: 24802662
[TBL] [Abstract][Full Text] [Related]
17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
18. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.
Pruitt K; Ulkü AS; Frantz K; Rojas RJ; Muniz-Medina VM; Rangnekar VM; Der CJ; Shields JM
J Biol Chem; 2005 Jun; 280(24):23363-70. PubMed ID: 15831492
[TBL] [Abstract][Full Text] [Related]
19. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
20. Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development.
Basu A; Datta D; Zurakowski D; Pal S
J Biol Chem; 2010 Aug; 285(33):25196-202. PubMed ID: 20554520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
